<html>
<head>PUBMED IDs for B56beta</head>
<body bgcolor='#C5F0F2'><h1>B56beta</h1><a href='https://pubmed.ncbi.nlm.nih.gov/8812429/'>Assignment of human protein phosphatase 2A regulatory subunit genes b56alpha, b56beta, b56gamma, b56delta, and b56epsilon (PPP2R5A-PPP2R5E), highly expressed in muscle and brain, to chromosome regions 1q41, 11q12, 3p21, 6p21.1, and 7p11.2 --&gt; p12.</a> August 15  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/8703017/'>The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm.</a> September 6  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/10734082/'>Protein phosphatase 2A and phosphatidylinositol 3-kinase regulate the activity of Sp1-responsive promoters.</a> March 29  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/16276521/'>The glycine 90 to aspartate alteration in the Abeta subunit of PP2A (PPP2R1B) associates with breast cancer and causes a deficit in protein function.</a> November 9  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/18385213/'>B56beta, a regulatory subunit of protein phosphatase 2A, interacts with CALEB/NGC and inhibits CALEB/NGC-mediated dendritic branching.</a> April 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18385200/'>Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma.</a> April 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19901535/'>InAKTivation of insulin/IGF-1 signaling by dephosphorylation.</a> February 4  2009<br></body></html>
